Complement C1q subcomponent subunit B
AltitudeomicsDB
Protein Official symbol |
C1QB |
Aliases |
C1QB |
Chromosomal Location |
1 |
Length |
253 |
Uniprot ID |
P02746 |
EC number |
None |
Protein family Information(Pfam) |
PF00386;PF01391; |
PDB id |
1PK6;2JG8;2JG9;2WNU;2WNV;5HKJ;5HZF;6FCZ; |
InterPro ID |
IPR001073;IPR008160;IPR037573;IPR008983; |
dbSNP |
rs776292843 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
712 (C1QA) |
714 (C1QC) |
715 (C1R) |
721 (C4B) |
716 (C1S) |
720 (C4A) |
713 (C1QB) |
717 (C2) |
710 (SERPING1) |
1436 (CSF1R) |
712 (C1QA)
|
1.00
|
1.00
|
0.86
|
0.84
|
0.96
|
0.80
|
1.00
|
1.00
|
0.56
|
0.49
|
714 (C1QC)
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
0.12
|
0.10
|
715 (C1R)
|
0.86
|
1.00
|
1.00
|
0.77
|
0.86
|
0.71
|
0.86
|
0.86
|
0.46
|
0.41
|
721 (C4B)
|
0.84
|
1.00
|
0.77
|
1.00
|
0.81
|
0.77
|
0.84
|
0.84
|
0.49
|
0.41
|
716 (C1S)
|
0.96
|
1.00
|
0.86
|
0.81
|
1.00
|
0.74
|
0.96
|
0.96
|
0.61
|
0.55
|
720 (C4A)
|
0.80
|
1.00
|
0.71
|
0.77
|
0.74
|
1.00
|
0.80
|
0.80
|
0.35
|
0.31
|
713 (C1QB)
|
1.00
|
1.00
|
0.86
|
0.84
|
0.96
|
0.80
|
1.00
|
1.00
|
0.56
|
0.49
|
717 (C2)
|
1.00
|
1.00
|
0.86
|
0.84
|
0.96
|
0.80
|
1.00
|
1.00
|
0.56
|
0.49
|
710 (SERPING1)
|
0.56
|
0.12
|
0.46
|
0.49
|
0.61
|
0.35
|
0.56
|
0.56
|
1.00
|
0.48
|
1436 (CSF1R)
|
0.49
|
0.10
|
0.41
|
0.41
|
0.55
|
0.31
|
0.49
|
0.49
|
0.48
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
C1QB |
Human |
Serum |
- |
2400 m |
0.5 hours |
downregulated |
0.157 |
2-DE |
Western Europe |
Germans |
0.193 |
Healthy adults never had ear surgery or problems with pressure equalization |
28858246 |
Association with TF
TF |
TF Entrez |
Gene |
Gene Entrez |
Type |
PMID |
Database |
Association with miRNA
miRTarBase ID |
miRNA |
Species (miRNA) |
Protein Official Symbol |
Human Entrez ID |
Species (Target Gene) |
Experiments |
Support Type |
References (PMID) |
MIRT030305 |
hsa-miR-26b-5p |
Homo sapiens |
C1QB |
713 |
Homo sapiens |
Microarray |
Functional MTI (Weak) |
19088304 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
713 |
GO:0005581 |
collagen trimer |
GOTERM_CC_DIRECT |
713 |
GO:0045087 |
innate immune response |
GOTERM_BP_DIRECT |
713 |
GO:0005515 |
protein binding |
GOTERM_MF_DIRECT |
713 |
GO:0042803 |
protein homodimerization activity |
GOTERM_MF_DIRECT |
713 |
GO:0005602 |
complement component C1 complex |
GOTERM_CC_DIRECT |
713 |
GO:0006956 |
complement activation |
GOTERM_BP_DIRECT |
713 |
GO:0005576 |
extracellular region |
GOTERM_CC_DIRECT |
713 |
GO:0006958 |
complement activation |
GOTERM_BP_DIRECT |
713 |
GO:0006508 |
proteolysis |
GOTERM_BP_DIRECT |
713 |
GO:0048839 |
inner ear development |
GOTERM_BP_DIRECT |
713 |
GO:0004252 |
serine-type endopeptidase activity |
GOTERM_MF_DIRECT |
713 |
GO:0070062 |
extracellular exosome |
GOTERM_CC_DIRECT |
713 |
GO:0072562 |
blood microparticle |
GOTERM_CC_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
713 |
hsa04610 |
Complement and coagulation cascades |
713 |
hsa05020 |
Prion diseases |
713 |
hsa05133 |
Pertussis |
713 |
hsa05150 |
Staphylococcus aureus infection |
713 |
hsa05142 |
Chagas disease |
713 |
hsa05322 |
Systemic lupus erythematosus |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
C1QB |
713 |
C1q DEFICIENCY |
C3150902 |
Disease or Syndrome |
0.71 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Ovarian Cysts |
C0029927 |
Disease or Syndrome |
0.3 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Antibody Deficiency Syndrome |
C0003257 |
Disease or Syndrome |
0.3 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Immunologic Deficiency Syndromes |
C0021051 |
Disease or Syndrome |
0.3 |
0.72 |
0.379 |
group |
C1QB |
713 |
IGA Glomerulonephritis |
C0017661 |
Disease or Syndrome |
0.3 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Liver Cirrhosis |
C0023890 |
Disease or Syndrome |
0.3 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Myocardial Ischemia |
C0151744 |
Disease or Syndrome |
0.3 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Corpus Luteum Cyst |
C0010093 |
Disease or Syndrome |
0.3 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Fibrosis, Liver |
C0239946 |
Disease or Syndrome |
0.3 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Liver Cirrhosis, Experimental |
C0023893 |
Experimental Model of Disease |
0.3 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Schizophrenia |
C0036341 |
Mental or Behavioral Dysfunction |
0.31 |
0.72 |
0.379 |
disease |
C1QB |
713 |
Malignant neoplasm of breast |
C0006142 |
Neoplastic Process |
0.3 |
0.72 |
0.379 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |
C1QB |
713 |
6-FLUOROTRYPTOPHAN |
CHEMBL472222 |
CHEMBL472222 |
inhibitor |
C1QB |
713 |
FENFLURAMINE |
FENFLURAMINE |
CHEMBL87493 |
inhibitor |
C1QB |
713 |
FENCLONINE |
FENCLONINE |
CHEMBL1256351 |
inhibitor |
C1QB |
713 |
α-PROPYLDOPACETAMIDE |
ROPINIROLE |
CHEMBL589 |
inhibitor |